Johns Hopkins Medicine: Co-Located Cell Types Help Drive Aggressive Brain Tumors
February 08, 2025
February 08, 2025
BALTIMORE, Maryland, Feb. 8 (TNSres) -- Johns Hopkins Medicine issued the following news release:
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel Cancer Center (https://www.hopkinsmedicine.org/kimmel-cancer-center) Bloomberg~Kimmel Institute for Cancer Immunotherapy (https://www.hopkinsmedicine.org/kimmel-cancer-center/bloomberg-kimmel-i . . .
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel Cancer Center (https://www.hopkinsmedicine.org/kimmel-cancer-center) Bloomberg~Kimmel Institute for Cancer Immunotherapy (https://www.hopkinsmedicine.org/kimmel-cancer-center/bloomberg-kimmel-i . . .